Literature DB >> 28228834

Anti-Collapsing Response-Mediating Protein-5 Antibody-Positive Paraneoplastic Perioptic Neuritis without Typical Neurological Symptoms.

Nozomi Igarashi1, Hiromasa Sawamura1, Toshikatsu Kaburaki1, Makoto Aihara1.   

Abstract

A 68-year-old male presented with blurred vision in both eyes. Ophthalmoscopy revealed bilateral prominent disc swelling and vitritis. No systematic neurological symptoms were observed. Magnetic resonance imaging revealed bilateral meningeal enhancement of the optic nerve. Small cell carcinoma was found, and antibodies against collapsing response-mediating protein-5 (CRMP-5) were detected in the serum. Ophthalmological manifestations disappeared during a decrease in tumour size with treatment for the malignancy. This case report describes this rare case of anti-CRMP-5 antibody-positive paraneoplastic perioptic neuritis without neurological symptoms, showing that prompt diagnosis and timely treatment of the underlying tumour are crucial to prevent increased levels of autoantibodies and irreversible damage to the nervous system.

Entities:  

Keywords:  Anti-CRMP-5 antibody; paraneoplastic optic neuropathy; small cell lung carcinoma

Year:  2016        PMID: 28228834      PMCID: PMC5278783          DOI: 10.1080/01658107.2016.1241283

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  19 in total

Review 1.  Vogt-Koyanagi-Harada disease.

Authors:  Ghazala A Datoo O'Keefe; Narsing A Rao
Journal:  Surv Ophthalmol       Date:  2016-05-27       Impact factor: 6.048

Review 2.  Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung.

Authors:  M R Thambisetty; C R Scherzer; Z Yu; V A Lennon; N J Newman
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

3.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

4.  Paraneoplastic optic neuropathy and autoantibody production in small-cell carcinoma of the lung.

Authors:  J E Luiz; A G Lee; J L Keltner; C E Thirkill; E C Lai
Journal:  J Neuroophthalmol       Date:  1998-09       Impact factor: 3.042

Review 5.  Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.

Authors:  Shelley A Cross; Diva R Salomao; Joseph E Parisi; Thomas J Kryzer; Elizabeth A Bradley; Jonathan A Mines; Byron L Lam; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

6.  High-titer collapsin response-mediating protein-associated (CRMP-5) paraneoplastic optic neuropathy and Vitritis as the only clinical manifestations in a patient with small cell lung carcinoma.

Authors:  Edward Margolin; Andrew Flint; Jonathan D Trobe
Journal:  J Neuroophthalmol       Date:  2008-03       Impact factor: 3.042

Review 7.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

8.  Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes.

Authors:  J Pulido; S A Cross; V A Lennon; J Pulido; D Swanson; M Muench; D H Lachance
Journal:  Eye (Lond)       Date:  2007-08-24       Impact factor: 3.775

9.  Pancreatic neuroendocrine paraneoplastic optic neuropathy: confirmation with antibody to optic nerve and hepatic metastasis.

Authors:  Thomas L Slamovits; Jerome B Posner; Diane L Reidy; Charles E Thirkill; John L Keltner
Journal:  J Neuroophthalmol       Date:  2013-03       Impact factor: 3.042

10.  A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.

Authors:  Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Hiroshi Ohguro; Susumu Ishida
Journal:  BMC Ophthalmol       Date:  2014-01-16       Impact factor: 2.209

View more
  1 in total

1.  Late-onset Ocular Toxicity Presenting as Uveitis Caused by Crizotinib.

Authors:  Megumi Iseki; Toshikatsu Kaburaki; Makoto Aihara; Hiromasa Sawamura
Journal:  Neuroophthalmology       Date:  2021-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.